Affiliates of Apollo Global Management will acquire Covis Pharma BV from Cerberus Capital Management, with a planned closing date in the first quarter of 2020.
What you should know:
1. The transaction terms were not disclosed.
2. Covis Pharma CEO Michael Porter said the transaction will allow the company to build out its respiratory continuum of care and establish new therapeutic franchises.
3. Covis currently develops treatments for respiratory, cardiovascular, gastroenterology and central nervous system diseases.